Low rates of follow-up colonoscopy after an abnormal stool-based screening test may be improved by a simple quality performance measure, researchers said.
Full-dose challenges were safely conducted for ED patients with moderate, severe, or unknown beta-lactam allergies, thereby avoiding unnecessary penicillin skin testing and reducing suboptimal antibiotic use.